iPS Scientist Create Mouse Pancreases
A group of researchers have succeeded in creating mouse pancreases with the use of induced pluripotent stem cells, opening the door for a significant advance in regenerative medicine.
Battling Diabetes with Beta Cells
Professor Shimon Efrat from Tel Aviv University’s Sackler Faculty of Medicine, has developed a way to cultivate cells derived from insulin-producing beta cells from human tissue in the laboratory.
New Stem Cell Tools to Aid Drug Development
A collaborative team of scientists from Durham University and the North East England Stem Cell Institute have developed two synthetic molecules which can be used to coax stem cells to differentiate into other forms of tissue.
Stem Cell Sciences Announces the Creation of the World’s First Authentic Rat Embryonic Stem Cells from its Exclusively Licensed Technology
Stem Cell Sciences plc announced that two independent laboratories in the UK and USA have achieved germ-line transmission from embryonic stem cells in rats using technologies exclusively licensed to the company by Edinburgh University.
Researchers Devise Means to Create Blood by Identifying Earliest Stem Cells
Johns Hopkins researchers have discovered the earliest form of human blood stem cells and deciphered the mechanism by which these embryonic stem cells replicate and grow.
Stem Cell Research Puts Interstate Rivalry on Hold
Scientists from the Monash Institute of Medical Research and colleagues from New South Wales will compare two different methods of creating patient-specific stem cells: somatic cell nuclear transfer and induced pluripotent stem cells.
Cardiac Cell Transplant Studies Show Promise in Cardiac Tissue Repair
Two studies published in the current issue of CELL TRANSPLANTATION (17:6) found that cardiomyocytes and bone marrow cells can assist and compliment each other when transplanting bone marrow cells for the repair of heart tissue.
Introgen Receives Notice ADVEXIN(R) U.S. BLA Not Sufficiently Complete to File
Introgen Therapeutics, Inc. recently announced that the United States Food and Drug Administration notified the Company that its Biologics License Application for ADVEXIN(R) (p53 gene tumor suppressor therapy) for the treatment of recurrent, refractory squamous cell carcinoma of the head and neck, submitted on June 30, 2008, was not sufficiently complete and would not be filed at this time.
Stem Cell Therapeutics Corp. Receives Positive Review from Data Safety & Monitoring Board
The REGENESIS Phase IIb clinical trial designed to demonstrate that the NTxTM-265 therapy is both a safe and effective therapy capable of improving recovery after acute ischemic stroke, has completed a safety analysis and has recommended the trial continue as per the protocol.
VIDEO: In vitro Labeling of Human Embryonic Stem Cells for Magnetic Resonance Imaging
In this video, the researchers show how to label hESC with MnCl2 and how those cells can be clearly seen by using MRI in vitro.
ABSTRACTS, REVIEWS AND SPECIAL REPORTS
Neural Stem Cell Transplantation can Ameliorate the Phenotype of a Mouse Model of Spinal Muscular Atrophy
Researchers at the University of Milan have generated data using a mouse model of spinal muscular atrophy to suggest that spinal cord neural stem cells might be a possible treatment for individuals with spinal muscular atrophy.
Hepatic Progenitor Cells from Adult Human Livers for Cell Transplantation
Bipotential progenitor cells from human adult livers can be isolated using Thy-1 and might be a potential candidate for cell treatment in liver diseases.
Previous Claims of SiRNA Therapeutic Effects Called into Question by Report in Human Gene Therapy
The many recent reports documenting the therapeutic efficacy of short interfering RNAs (siRNAs) in animal models of human disease may actually be describing non-specific therapeutic effects related to the ability of siRNA to activate an immune response, according to a new paper.
Culturing Human Embryonic Stem Cells with Mouse Embryonic Fibroblast Feeder Cells
Here the researchers describe an efficient method for culturing and passaging hESCs by enzyme (collagenase) for culture on irradiated mouse embryonic fibroblasts.
R&D Manager-Cell Technologies
Cellular Therapy Laboratory Manager
Recruit Top Talent
Reach more than 11,000 potential candidates by posting your organization’s career opportunities with Cell Therapy News.
Visit this Link
to post your career opportunities.